Jun Tang, Ph.D.

Senior Manager, CRI Venture Fund and Clinical Accelerator
New York | Email | (212) 688-7515 x228

Jun joined the Cancer Research Institute in January 2017 as a senior research analyst in the Clinical Accelerator program. Since July 2018, he has been the Senior Manager of Clinical Accelerator and leading the diligence research, academic publication, and consulting services of the Clinical Accelerator program.

Prior to CRI, Jun spent more than a decade as a scientist in immunology and biomedical engineering. He received his bachelor's degree in bioengineering in 2005 and a master degree in biochemistry in 2008 in China. He continued graduate study in the U.S. and received his Ph.D. in 2014 from Icahn School of Medicine at Mount Sinai, where he developed nanomaterial-based immunotherapies for cardiovascular diseases and cancer. He completed a postdoctoral fellowship at Memorial Sloan Kettering Cancer Center in 2017, where he developed cancer immunotherapies for solid tumors and imaging probes for PET imaging. Jun has published 33 peer-reviewed papers, given 12 conference presentations, won eight research awards, and filed one patent.

Jun strongly believes that cancer immunotherapy will revolutionize cancer treatment and save millions of lives.

Selected publications:

Changing the Way Cancer is Treated and Cured

Let's spread the word about Immunotherapy! Click to share this page with your community.

*Immunotherapy results may vary from patient to patient.